Verition Fund Management
CVRS

Verition Fund Management’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Verition Fund Management’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-43,458
Closed -$76K – 1527
2019
Q1 		$76K Buy
+43,458
New +$60.1K ﹤0.01% 1035

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Verition Fund Management's CVRS Position: Q2 2019 in Review

Verition Fund Management sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2019, closing a stake of 43,458 shares — an estimated $76K sold.

Verition Fund Management first reported a position in CVRS in Q1 2019 and held it in 1 quarter. The position peaked at $76K in Q1 2019. 81 funds tracked by Wall St. Rank hold CVRS as of Q2 2019.

  • Verition Fund Management reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q2 2019 after selling out during the quarter.
  • Verition Fund Management sold 43,458 CORINDUS VASCULAR ROBOTICS, INC shares in Q2 2019, an estimated $76K.
  • Verition Fund Management first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q1 2019 and held it in 1 quarter.
  • Verition Fund Management's CORINDUS VASCULAR ROBOTICS, INC position peaked at $76K in Q1 2019.
  • 81 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2019.

Based on Verition Fund Management's 13F filing for Q2 2019, filed 14 Aug 2019.